Editorial: Contemporary applications of machine learning and artificial intelligence for the management of heart

Andre Rodrigues Duraes1, Mansueto Gomes-Neto1, Edimar Alcides Bocchi2

  • 1Federal University of Bahia (UFBA), Salvador, Brazil.

Insights

Machine learning and artificial intelligence (AI) are revolutionizing heart failure (HF) management. These advanced technologies offer new ways to diagnose, stratify, and predict outcomes for patients with HF.

Area of Science:

  • Cardiovascular Medicine
  • Biomedical Data Science
  • Computational Biology

Background:

  • Heart failure (HF) presents significant clinical and economic challenges.
  • Contemporary management of HF requires innovative approaches for diagnosis, risk stratification, and patient monitoring.

Discussion:

  • This editorial reviews four studies applying machine learning (ML) and artificial intelligence (AI) to HF.
  • The reviewed articles explore AI's role in early diagnosis via novel biomarkers, disease stratification using transcriptomics, understanding apoptotic pathways, and predictive telemonitoring.
  • Integration of these data-driven technologies into routine clinical practice is discussed, highlighting potential benefits and challenges.

Key Insights:

  • AI and ML enable early diagnosis of heart failure using novel biomarkers.
  • Transcriptomics combined with AI aids in accurate disease stratification.
  • Real-time AI models enhance predictive telemonitoring for preventing decompensation.
  • Data-driven approaches promise personalized care strategies for HF patients.

Outlook:

  • The transformative potential of AI and ML in personalizing HF care is significant.
  • Future integration of these technologies could lead to improved patient outcomes and reduced healthcare costs.
  • Addressing the challenges in implementation is crucial for realizing the full benefits of AI in HF management.

Related Concept Videos

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
1.5K
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
619
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
567
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
602
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
746
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
702